Workflow
4K荧光腹腔镜
icon
Search documents
海泰新光探微见真章
Zheng Quan Ri Bao· 2025-08-15 16:49
Core Viewpoint - Qingdao Haitai Newlight Technology Co., Ltd. has made significant advancements in the endoscope industry, particularly with its 4K fluorescence laparoscope, which features a unique fog removal technology that enhances surgical visibility and efficiency [1][3]. Group 1: Company Development and Technology - Haitai Newlight started with optical coating technology and successfully transitioned into the endoscope market by leveraging key technological opportunities, such as LED light sources and fluorescence laparoscopes [1][2]. - The company has achieved multiple critical technological breakthroughs, including a 4K fluorescence laparoscope that maintains distortion control below 10%, significantly better than the industry average [2][3]. - The self-developed laser coaxial coupling fog removal technology improves surgical visibility by 80% and is set to be mass-produced in 2024, enhancing market competitiveness [3]. Group 2: Innovation and Market Strategy - Haitai Newlight's multi-spectral lighting design has increased the light utilization rate in medical endoscopes from 60% to 85%, showcasing its commitment to innovation [4]. - The company is focusing on developing ultra-thin endoscopes, reducing the diameter from 10.5 mm to 2.7 mm, with ongoing efforts to achieve optical apertures smaller than 1 mm [5]. - Haitai Newlight has established a layered R&D system to ensure that its products meet the real needs of clinical applications, aiming to lead the high-end medical market [7]. Group 3: Market Position and Future Outlook - The domestic hard endoscope market is projected to reach 15.1 billion yuan by 2030, indicating rapid industry growth, yet most local manufacturers remain focused on low-end products [6]. - Haitai Newlight is adopting a dual-channel strategy, combining its own sales team with partnerships, such as the joint venture with China National Pharmaceutical Group, to enhance market reach [9]. - The company has achieved a stable overseas revenue share of 70%, balancing local R&D with overseas assembly to mitigate risks associated with international trade [10]. - Haitai Newlight emphasizes innovation over price competition, aiming to redefine industry standards through technological advancements and product upgrades [10].
记者手记丨在援外医院感受中圭跨越山海的情谊
Xin Hua Wang· 2025-04-28 03:41
Core Insights - The article highlights the long-standing friendship and cooperation between China and Guyana through the Chinese medical team's efforts in providing healthcare services in Georgetown, Guyana [1][2] Group 1: Medical Contributions - The Chinese medical team has been active in Georgetown Public Hospital since 1993, providing various medical services, including traditional Chinese medicine [1] - The establishment of the Chinese Medical Team's Traditional Chinese Medicine Center in 2023 marks a significant step in promoting Chinese medical culture in Guyana [1] - The team has introduced advanced medical equipment, such as 4K fluorescence laparoscopes, and has conducted training on new techniques in collaboration with local doctors [2] Group 2: Local Impact and Training - Local patients have shown increasing acceptance of traditional Chinese medicine, with many seeking acupuncture treatments that have proven effective for chronic pain relief [1] - Guyanese doctors, such as Dr. Ramju, are eager to learn from Chinese medical practices, with plans to undergo training in China to enhance their skills in liver and gallbladder surgery [2] - The leadership of Georgetown Public Hospital values the partnership with the Chinese medical team, acknowledging the positive impact on local healthcare capabilities and patient care [2]
CMEF2025!医学影像区新品速览
思宇MedTech· 2025-04-07 11:13
报名:首届全球眼科大会 | 议程更新 那么,本次 医学影像展区 都将展出哪些创新产品呢?一起来看看吧! # GE医疗 展位 :3R13 展品 : "英雄"磁共振结合"Sonic深度学习平台" GE医疗 是一家全球领先的医疗科技、诊断药物和数字化解决方案的创新企业,致力于通过整合解决方案和服 务提升医疗效率和精准度。公司业务遍及 160多个国家和地区 ,年营收超196亿美元,拥有全球员工51,000 名。 GE医疗的 SIGNA Hero磁共振设备通过搭载人工智能深度学习Sonic平台 ,实现了"脑心同治"理念的落地。该 设备将传统超过一小时的检查时间缩短至半小时,仅需一次造影剂注射即可完成脑心联合评估,大幅提升检查 效率和成功率。此外,SIGNA Hero还具备 高分辨斑块成像功能 ,能够评估缺血性脑卒中和心脏病风险,为不 明原因卒中患者提供全面诊断信息。 基于SIGNA Hero的脑心同治及肿瘤精准诊疗应用方案已入选《2024年高端医疗装备推广应用项目》,并由天 津医科大学总医院牵头,联合多家医院进行临床应用研究。 # 飞利浦医疗 报名:首届全球骨科大会 | 议程更新 报名:首届全球心血管大会 | 奖项申报 ...